CLINICAL DRUG DEVELOPMENT SL

Hoja B499784· NIF B66958943

Struck off · 15/07/2024Barcelona
Registered address :
Activity :
Otra investigación y desarrollo experimental en ciencias naturales y técnicas
Legal form :
Sociedad Limitada (SL)
Share capital :
3 800,00 €
Incorporation :
15/03/2017

Legal information

Legal information for CLINICAL DRUG DEVELOPMENT SL

NIF
Hoja registral
IRUS1000374183368
Legal formSociedad Limitada (SL)
Share capital3 800,00 €
Incorporation date15/03/2017
LocalityBarcelona
Registro MercantilBARCELONA
Register referenceTomo 45809 · Folio 188 · Hoja B499784
StatusExtinguida

Activity

CLINICAL DRUG DEVELOPMENT SL is a Sociedad Limitada (SL) with its registered office in Barcelona (Cataluña). Its declared activity is “Otra investigación y desarrollo experimental en ciencias naturales y técnicas” (CNAE 7219). It was incorporated on 15 March 2017. The Spanish commercial register has published 6 filings for this company, from 15 March 2017 to 15 July 2024, across 5 distinct types of filing. Its registered share capital is 3 800,00 €. It appears in the register as “Extinguida”.

Economic activity (CNAE)

7219 · Otra investigación y desarrollo experimental en ciencias naturales y técnicas

Corporate purpose

ACTIVIDAD PRINCIPAL: 7219 OTRA INVESTIGACION Y DESARROLLO EXPERIMENTAL EN CIENCIAS NATURALES Y TECNICAS. EL ASESORAMIENTO Y CONSULTORIA EN EL AMBITO BIOMEDICO.

Directors and representatives

Directors

Former

Directors network map

2 nodes Person Company
CLINICAL DRUG DEVELOP…Anne Rachel LeselbaumAnne Rachel Leselbaum

Registered actos

  1. RevocacionesPublished 15/07/2024· Registered 08/07/2024· I/A 3
  2. NombramientosPublished 15/07/2024· Registered 08/07/2024· I/A 3
  3. ExtinciónPublished 15/07/2024· Registered 08/07/2024· I/A 3
  4. Ampliación de capitalPublished 20/09/2021· Registered 10/09/2021· I/A 2
  5. ConstituciónPublished 15/03/2017· Registered 07/03/2017· I/A 1
  6. NombramientosPublished 15/03/2017· Registered 07/03/2017· I/A 1

Changes

  1. 15/07/2024Extinción

Capital · events

  1. 20/09/2021Ampliación de capital
    Resulting capital: 3 800,00 € (+800,00 €)
  2. 15/03/2017Constitución
    Initial capital: 3 000,00 €

Importes obtenidos del BORME cuando se publican (importe de la operación y capital resultante). Algunos anuncios no lo publican; en ese caso consulte el PDF original.

Timeline (BORME)

  1. 15/07/2024#8168828
    RevocacionesNombramientosExtinción
    CLINICAL DRUG DEVELOPMENT SL. Revocaciones. ADM.UNICO: ANNE RACHEL LESELBAUM. LIQUIDADOR: ANNE RACHEL LESELBAUM. Nombramientos. LIQUIDADOR: ANNE RACHEL LESELBAUM. Extinción. Datos registrales. S 8 , H B 499784, I/A 3 ( 8.07.24).
  2. 20/09/2021#6608574
    Ampliación de capital
    CLINICAL DRUG DEVELOPMENT SL. Ampliación de capital. Capital: 800,00 Euros. Resultante Suscrito: 3.800,00 Euros. Otros conceptos: DECLARACION DE PERDIDA DE UNIPERSONALIDAD. Datos registrales. T 45809 , F 188, S 8, H B 499784, I/A 2 (10.09.21).
  3. 15/03/2017#4290071
    ConstituciónNombramientos
    CLINICAL DRUG DEVELOPMENT SL. Constitución. Comienzo de operaciones: 27.02.17. Objeto social: ACTIVIDAD PRINCIPAL: 7219 OTRA INVESTIGACION Y DESARROLLO EXPERIMENTAL EN CIENCIAS NATURALES Y TECNICAS. EL ASESORAMIENTO Y CONSULTORIA EN EL AMBITO BIOMEDI…

Official documents

Official Registro Mercantil documents that we obtain and deliver to you as PDFs.

Nota informativa mercantil (company extract)

Current registry status: administradores and apoderados with their DNI, objects, capital, registered address and latest accounts filing.

Public

Filed annual accounts

Actual image of the filing for each financial year: balance sheet, profit and loss account and shareholder structure.

Public

Certified articles of association

The company's articles of association in force, certified by the registrador.

Public· Incorporated 2017

Certificate of powers of attorney

Powers in force held by a given apoderado (state their NIF or name).

Public

Certificate of good standing and current officers

Conclusive certificate of existence, good standing and the cargos currently in office.

Public

Certificate of beneficial ownership

The company's official beneficial owners.

Requires a legitimate interest (shareholder, director or obliged entity)

Credit risk report

Commercial credit risk report on the company.

Public

Official documents from Spain's Registro Mercantil · delivered as PDFs. Price set by the official arancel, we send a quote once you request one.

Contact details

WebsitesReserved for registered users
PhoneReserved for registered users
EmailReserved for registered users
Social networks
Full addressPS REINA ELISENDA DE MONTCADA 13 D P.3 PTA.2 (BARCELONA), Barcelona
Other linked sitesReserved for registered users
Published addressesReserved for registered users
Opening hoursReserved for registered users

Prospect

Spanish companies in the same line of business — Otra investigación y desarrollo experimental en ciencias naturales y técnicas — are listed together.

Prospect this sectorAll companies in this sector